BTSG (BrightSpring Health Services) Debt-to-EBITDA : 4.20 (As of Mar. 2026) — 55% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BTSG BrightSpring Health Services Inc BTSG
40 GF Score
Price $72.91
! 7 Warning Signs
View Full Analysis

What is BrightSpring Health Services Debt-to-EBITDA?

BrightSpring Health Services BTSG +4.44% 40 Debt-to-EBITDA is 4.20 as of Mar. 2026, which is 55% below its 10-year median of 9.31. GuruFocus rates BTSG with a GF Score™ of 40/100. The stock has 7 warning signs investors should review. Among 478 Healthcare Providers & Services companies, BrightSpring Health Services ranks worse than 75.94% on this metric.

Debt-to-EBITDA measures a company's ability to pay off its debt.

BrightSpring Health Services's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was $105 Mil. BrightSpring Health Services's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was $2,595 Mil. BrightSpring Health Services's annualized EBITDA for the quarter that ended in Mar. 2026 was $642 Mil. BrightSpring Health Services's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 was 4.20.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for BrightSpring Health Services's Debt-to-EBITDA or its related term are showing as below:

BTSG' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 5.12   Med: 9.31   Max: 14.09
Current: 5.12

During the past 8 years, the highest Debt-to-EBITDA Ratio of BrightSpring Health Services was 14.09. The lowest was 5.12. And the median was 9.31.

BTSG's Debt-to-EBITDA is ranked worse than
75.94% of 478 companies
in the Healthcare Providers & Services industry
Industry Median: 2.25 vs BTSG: 5.12

BrightSpring Health Services  (NAS:BTSG) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


BrightSpring Health Services Debt-to-EBITDA Related Terms


BrightSpring Health Services Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for BrightSpring Health Services's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BrightSpring Health Services Debt-to-EBITDA Chart

BrightSpring Health Services Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-EBITDA
Get a 7-Day Free Trial 8.70 9.39 14.09 9.31 5.89

BrightSpring Health Services Quarterly Data
Sep20 Dec20 Jun21 Sep21 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.31 7.50 5.25 4.58 4.20

BTSG vs TEM, HQY, HNGE: Debt-to-EBITDA Comparison

For the Health Information Services subindustry, BrightSpring Health Services's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BrightSpring Health Services Debt-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BrightSpring Health Services's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where BrightSpring Health Services's Debt-to-EBITDA falls into.


BTSG
40GF Score
BrightSpring Health Services Inc BTSG
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BrightSpring Health Services Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

BrightSpring Health Services's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(102.07 + 2605.168) / 459.529
=5.89

BrightSpring Health Services's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(105.088 + 2594.616) / 642.172
=4.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of 4.20 mean?
BrightSpring Health Services (BTSG) has a Debt-to-EBITDA of 4.20 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on BrightSpring Health Services. This is 55% below median its historical median of 9.31. Over the past decade, BrightSpring Health Services' Debt-to-EBITDA has ranged from 5.12 to 14.09. According to the industry distribution chart, BrightSpring Health Services ranks #363 out of 478 companies in the Healthcare Providers & Services industry, placing it in the top 75.9%.
Is BrightSpring Health Services' Debt-to-EBITDA too high?
BrightSpring Health Services' current Debt-to-EBITDA of 4.20 is 55% below median its 10-year median of 9.31. Over the past 10 years, this metric has ranged from a low of 5.12 to a high of 14.09. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.25. BrightSpring Health Services' value of 4.20 is 86.7% above this industry median. Based on the distribution chart, BrightSpring Health Services ranks #363 out of 478 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, BrightSpring Health Services has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does BrightSpring Health Services' Debt-to-EBITDA compare to TEM and HQY?
According to the Healthcare Providers & Services industry distribution chart, BrightSpring Health Services ranks #363 out of 478 companies for Debt-to-EBITDA. This places BrightSpring Health Services in the lower half of its industry. The industry median Debt-to-EBITDA is 2.25. BrightSpring Health Services' value of 4.20 is 86.7% above this benchmark. Historically, BrightSpring Health Services' own Debt-to-EBITDA has ranged from 5.12 to 14.09 over the past decade. While the company's 10-year median is 9.31 vs. the industry median of 2.25, BrightSpring Health Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.25, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BrightSpring Health Services's current Debt-to-EBITDA of 4.20 is 86.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on BrightSpring Health Services. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BrightSpring Health Services's current Debt-to-EBITDA is 4.20, which is 55% below median its own 10-year median of 9.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BrightSpring Health Services stock overvalued right now?
BrightSpring Health Services (BTSG) has a current Debt-to-EBITDA of 4.20. The current Debt-to-EBITDA is 4.20, which is 55% below median its 10-year median of 9.31 and 86.7% above the Healthcare Providers & Services industry median of 2.25. BrightSpring Health Services' overall GF Score™ is 40/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For BrightSpring Health Services (BTSG), the current Debt-to-EBITDA is 4.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BrightSpring Health Services Business Description

Address 805 N. Whittington Parkway, Louisville, KY, USA, 40222
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services, and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
40GF Score

Get the complete analysis for BTSG

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$72.91
Price